Pfizer’s main stock price holds around $28, influenced by diversification into oncology and rare disease pipelines. Investors note technical support at $27, with momentum picking up after recent FDA approvals. The Fed released a new edition of its quarterly Summary of Economic Projections (SEP) at its September meeting. It tells the public where members of the Federal Open Market Committee (FOMC) expect interest rates, economic growth, inflation, and the unemployment rate to be over the next couple of years. Core & Main, Inc is a specialty distributor focused on water, wastewater, storm drainage and fire protection products, and related services. The company provides infrastructure solutions to municipalities, private water companies and professional contractors across municipal, non-residential, and residential end markets, nationwide. Read More Five stocks we like better than Core & Main What Are the FAANG Stocks and Are They Good Investments? FuelCell Energy's Stock: Is a Fundamental Breakout Underway? Breakout Stocks: What They Are and How to Identify Them Palantir’s Commercial Growth Story Is Just Getting Started How to Capture the Benefits of Dividend Increases $100 Million Buyback in Upwork Stock Follows a Strong Quarter Should You Invest $1,000 in Core & Main Right Now? Before you consider Core & Main, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core & Main wasn't on the list. While Core & Main currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here Beginner's Guide To Retirement Stocks Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Goldman Sachs’ main stock price rests at $395 as M&A activity returns to pre-2022 levels. Sector performance indicates stable earnings growth potential in investment banking and asset management portfolios.